The "BH3-only" proapoptotic BCL-2 family members are sentinels of intracellular damage. Here, we demonstrated that the BH3-only BID protein partially localizes to the nucleus in healthy cells, is important for apoptosis induced by DNA damage, and is phosphorylated following induction of double-strand breaks in DNA. We also found that BID phosphorylation is mediated by the ATM kinase and occurs in mouse BID on two ATM consensus sites. Interestingly, BID −/− cells failed to accumulate in the S phase of the cell cycle following treatment with the topoisomerase II poison etoposide; reintroducing wildtype BID restored accumulation. In contrast, introducing a nonphosphorylatable BID mutant did not restore accumulation in the S phase and resulted in an increase in cellular sensitivity to etoposide-induced apoptosis. These results implicate BID as an ATM effector and raise the possibility that proapoptotic BID may also play a prosurvival role important for S phase arrest.
noncleavable BID mutant sensitized BID
−/− mouse embryonic fibroblasts (MEFs) to DNA damage-induced apoptosis (Sarig et al., 2003) . Our current findings demonstrate that BID is partially localized to the nucleus in healthy MEFs and is important for apoptosis induced by a variety of DNA-damaging reagents. Moreover, we show that etoposide and ionizing radiation, both of which are known to induce double-strand breaks in DNA, lead to the phosphorylation of BID. Our findings indicate that BID phosphorylation is mediated by the ATM kinase, and occurs in mouse BID on two ATM consensus sites (S 61 Q and S 78 Q). We also found that etoposide induced accumulation of BID +/+ MEFs in the S and G 2 phases of the cell cycle, whereas such an accumulation was not observed in the BID −/− MEFs. Reintroducing wild-type BID into BID −/− cells restored their ability to accumulate in the S and G 2 phases, whereas introducing a nonphosphorylatable BID mutant (S61A/ S78A) restored accumulation in the G 2 phase but not in the S phase. Moreover, in response to etoposide, the mutant BID cells entered apoptosis more readily than did the wild-type BID cells. These results implicate BID as an ATM effector and raise the novel possibility that BID, a molecule that was previously considered to be active only as a proapoptotic factor, may also play a prosurvival role important for S phase arrest.
Results

BID Is Important for DNA Damage-Induced Apoptosis
To determine whether BID is required for DNA damageinduced apoptosis, we generated hTERT-immortalized BID +/+ and BID −/− mouse embryonic fibroblasts and analyzed their response to a variety of DNA-damaging reagents: etoposide (Etop; a specific inhibitor of topoisomerase II), cisplatin (Cis; forms covalent adducts with the DNA), ultraviolet radiation (UV; induces thymine dimers), and ionizing radiation (IR). We found that BID −/− MEFs were less susceptible than BID +/+ MEFs to all four treatments ( Figure 1A ). These DNA-damaging reagents also induced less cell death in primary BID −/−
MEFs than in primary BID
+/+ MEFs (data not shown), confirming that this decreased sensitivity is not due to hTERT immortalization. Splenocytes from BID −/− mice also display less susceptibility to Etop treatment (see Figure S1A in the Supplemental Data available with this article online), indicating that the decreased death response to DNA damage is a general feature of BID deficiency, although it is more pronounced in MEFs.
To confirm that BID −/− MEFs are indeed less sensitive than BID +/+ MEFs to DNA damage-induced cell death, we performed clonogenic survival assays with MEFs following DNA damage. Our studies show that BID 
DNA-Damaging Reagents Causing Double-Strand
Breaks Induce the Phosphorylation of BID, and This Phosphorylation Is Mediated by the ATM Kinase Next, we explored whether BID was modified in response to DNA damage. Western blot analysis using anti-BID antibodies on lysates of hTERT-immortalized BID +/+ MEFs treated with the DNA-damaging reagents mentioned above revealed that Etop and IR, which are known to induce DSBs in DNA, unlike Cis or UV, induced a double electrophoretic mobility shift in BID (Figure 2A , note that the lower of the two shifted bands does not separate well from the regular BID band). We also treated MEFs with several other apoptotic reagents: thapsigargin (Thaps; stress signaling from the ER, which inhibits the Ca 2+ adenosine triphosphate pump); TNFα together with actinomycin D; or with staurosporine (STS; a kinase inhibitor) and found that none of them affected the electrophoretic mobility of BID (Figure 2A ). Etop and IR induced a similar double electrophoretic mobility shift in BID also in primary BID +/+ MEFs (data not shown), confirming that this shift is not due to hTERT immortalization. Similar mobility shifts have been associated with covalent modifications of proteins, for example, as a consequence of phosphorylation.
To define whether the double electrophoretic mobility shift in BID was due to phosphorylation, BID +/+ MEFs were treated with Etop for 30 min, lysed, and either left untreated or incubated with alkaline phosphatase for 30 min at 37°C. Western blot analysis using anti-BID antibodies demonstrated that treatment with alkaline phosphatase abolished the electrophoretic mobility shifts in BID ( Figure 2B ), indicating that these shifts are most likely due to phosphorylation. Taken together, these results strongly suggest that BID is rapidly phosphorylated in response to reagents that induce doublestrand breaks in DNA.
To confirm that BID was phosphorylated, human cervical adenocarcinoma (HeLa) cells were transfected with mouse BID, labeled with 32 P-orthophosphate, either left untreated or treated with Etop, and BID-immunoprecipitated. Exposure to Etop resulted in a marked increase in 32 P-labeling of BID, which appeared as a doublet ( Figure 2C, left) . Western blot analysis of the same samples with anti-BID antibodies indicated that the two 32 P-labeled bands correspond to the two slower-migrating forms of BID ( Figure 2C, right) .
The ATM kinase plays a pivotal role in the immediate response of cells to double-strand breaks. To determine whether ATM is involved in the phosphorylation of BID, we utilized mouse embryonic fibroblasts deficient in both ATM and the p19ARF tumor-suppressor gene, since loss of ARF has been shown to reverse premature replicative arrest of ATM-deficient MEFs (Kamijo et al., 1999). Accordingly, ATM/ARF double-knockout MEFs, Mouse and Human BID Are Phosphorylated on PIKK Consensus Sites As mentioned in the Introduction, ATM is a member of the PIKK family. The common phosphorylation sites for PIKKs are serines or threonines followed by glutamine residues, a motif commonly dubbed "SQ/TQ" (Kim et al., 1999) . Mouse BID carries two such motifs (S 61 Q and S 78 Q), whereas human and rat BID carry only one (S 78 Q; Figure 3A ).
To determine whether mouse BID is phosphorylated on one or both of these sites, we mutated each of these serines to alanines. Our initial analysis was performed in HeLa cells transfected with either wild-type (wt) BID or transfected with one or the other of the BID mutants. Western blot analysis using anti-BID antibodies indicated that treatment of the aforementioned cells with Etop resulted in a double electrophoretic mobility shift, which was abolished in the S61A mutant ( Figure 3B ). In contrast, mutating the S78 site had no effect on the appearance of the two slower-migrating bands. Thus, BID phosphorylation on S61 is likely the cause for the electrophoretic mobility shift. To confirm the results presented above and to establish whether serine 78 is also phosphorylated in mouse BID in response to Etop, we generated phosphospecific antibodies to serine 61 and serine 78 (see Experimental Procedures). We initially performed Western blot analysis with these antibodies on lysates of mouse embryonic fibroblasts. To define whether these antibodies recognize the phosphorylated form of BID, BID To determine if ATM (and possibly ATR) could directly phosphorylate BID, we performed in vitro kinase assays using flag-tagged human ATM and ATR (and the kinaseinactive forms) and purified recombinant mouse wtBID and the BID-S61A/S78A double mutant. Wild-type but not kinase-inactive human ATM and ATR efficiently phosphorylate recombinant wtBID in vitro, whereas mutating both S61 and S78 completely abolished BID phosphorylation ( Figure S2B ). Taken together, these data indicate that BID is a substrate of both ATM and ATR in vitro and that S61 and/or S78 are the sites phosphorylated by these kinases.
To determine whether BID is phosphorylated in another cell type, we have examined the phosphorylation status of BID in mouse splenocytes either not treated or treated with Etop. As shown in Figure S2C , Etop induces the phosphorylation of BID on both S61 and S78 in splenocytes.
As mentioned above, human BID carries only one PIKK consensus site (S78; Figure 3A) . To determine whether endogenous human BID is phosphorylated on S78, we performed Western blot analysis with antihuman BID and anti-pS78 antibodies on lysates of HEK293 cells either not treated or treated with Etop. The anti-pS78 antibodies recognized a band of the size of human BID only in cells treated with Etop ( Figure  S2D ). To confirm these results, we cloned human BID, generated a human BID-S78A mutant, and expressed either the wild-type or the mutant BID in HeLa cells. Western blot analysis using anti-pS78 antibodies showed an increase in the intensity of the band that represents phosphorylated BID in cells transfected with wild-type human BID but not in cells transfected with To show that phosphorylation of mouse BID was specific for reagents inducing double-strand breaks, we treated mouse embryonic fibroblasts with several DNAdamaging and other apoptotic reagents (previously described in Figure 2) . Posttreatment, cells were lysed, and the phosphorylation of endogenous mouse BID was examined by Western blot analysis using antipS61 antibodies. The results demonstrated that mouse BID is phosphorylated on S61 only in response to reagents that induce double-strand breaks ( Figure 3F) .
Finally, to define whether phosphorylation of human BID was also ATM-dependent and occurred only in response to reagents that induce double-strand breaks, we took advantage of a stable HEK293 cell line in which ATM was knocked down by siRNA (these cells were generated To assess whether BID indeed localizes to the nucleus in healthy MEFs, we have performed subcellular fractionations followed by Western blotting using anti-BID antibodies. In these experiments, cellular BID was detected only in the soluble/cytoplasmic fraction (Figure 4B, left top panel) . MEK and BAX (cytosolic proteins) and lamin B (a nuclear protein) were used as markers to confirm the purity of the nuclear/cytoplasmic fractions ( Figure 4B, left bottom panels) . These results, together with the immunofluoresence results, suggested that BID might be loosely associated with the nuclear fraction and that cellular disruption leads to its dissociation from this fraction. To examine this possibility, cells were treated with formaldehyde as a crosslinker prior to cellular disruption. These experiments demonstrated that a small fraction of cellular BID was localized to the nuclear fraction ( Figure 4B , right panels). These results suggest that BID is loosely associated with the nuclear fraction by interaction with another protein(s) and that crosslinking is required to preserve this interaction. To determine whether Etop treatment leads to a change in the levels of nuclear BID, cells were treated with Etop for 1 and 3 hr and then treated with formaldehyde followed by subcellular fractionation. We found that Etop did not change the levels 
of BID associated with the nuclear fraction (data not shown).
To determine the cellular location of the phosphorylated forms of BID, we performed immunofluoresence studies with the phosphospecific antibodies using BID +/+ and BID −/− MEFs either not treated or treated with Etop for 30 min. These antibodies detected an increase in nuclear fluorescence in BID +/+ MEFs treated with Etop; however, a similar increase was detected in BID −/− MEFs (data not shown). Thus, these antibodies crossreact with other phospho-S/T-Q proteins. Nonetheless, the fact that BID partially localizes to the nucleus and that all currently identified substrates of ATM are nuclear proteins, suggests that BID is phosphorylated in the nucleus.
To assess whether BID might be involved in the immediate cellular response to DNA damage, we next determined the earliest point at which BID in mouse embryonic fibroblasts was phosphorylated, following exposure to ionizing radiation. Phosphorylation of serine 61 was detectable immediately after exposing cells to 50 Gy IR ( Figure 4C) .
We previously determined that phosphorylation of BID on both serine 61 and serine 78 occurs several hours prior to the onset of apoptosis (Figure 3) . We therefore speculated that phosphorylation might also occur in response to extremely low levels of ionizing radiation which do not result in apoptosis. Indeed, we determined that a 25-fold lower dose of IR (0.2 Gy) was sufficient to induce phosphorylation of BID ( Figure 4D ). To assess whether ATM-mediated phosphorylation is regulating BID's function in this process, we generated BID −/− single stable clones expressing either wtBID or a nonphosphorylatable BID mutant (S61A/S78A). We initially confirmed that wtBID (in the wtBID clones) was phosphorylated on S61 and S78 in response to Etop and that BID-S61A/S78A (in the mutant BID clones) was not ( Figure 6A) .
BID
Next, we performed cell cycle analysis on two of the wtBID and two of the BID-S61A/S78A stable clones. As shown in Figure 6B , Etop induced accumulation of the wtBID clones in the S and G 2 phases of the cell cycle (as measured 8 hr after release into drug-free medium), whereas the mutant BID clones bypassed accumulation in the S phase and rapidly accumulated in the G 2 phase. Thus, the mutant BID cells were found to be impaired in their ability to temporarily arrest in S phase following double-strand break DNA damage. Figure 7A ). Western blot analysis using anti-BID antibodies indicated that the increase in apoptosis seen in the mutant BID clones in response to Etop was not due to either higher levels of expression of mutant BID or to its enhanced cleavage to tBID ( Figure 7B) . Thus, the mutant BID clones were found to be more susceptible to apoptotsis induced solely by a reagent that leads to DNA doublestrand breaks.
Discussion
In the present study, we demonstrated that double-strand break DNA-damaging reagents induced an immediate and transient phosphorylation of BID. In addition, we showed that this phosphorylation was mediated by the ATM kinase. Most importantly, we demonstrated that BID −/− mouse embryonic fibroblasts failed to delay the cell cycle in response to etoposide and that introduction of a nonphosphorylatable BID mutant restored delay in the G 2 but not in the S phase. Moreover, in response to etoposide, the mutant BID cells entered apoptosis more readily than did the wild-type BID cells.
Previously, we suggested that full-length BID is a player in the DNA-damage pathway, since a caspase-8 noncleavable BID mutant sensitized BID −/− mouse embryonic fibroblasts to DNA damage-induced apoptosis (Sarig et al., 2003) . Our current findings demonstrate that in MEFs, BID is important for apoptosis induced by a variety of DNA-damaging reagents (Figure 1) . Splenocytes from BID −/− mice also display less susceptibility to DNA damage, indicating that the decreased death response to DNA damage is a general feature of BID deficiency.
As mentioned above, BID −/− MEFs are less susceptible than BID +/+ MEFs to reagents that induce different forms of DNA damage (Figure 1) . On the other hand, BID phosphorylation occurs only in response to reagents that induce double-strand breaks in DNA. Thus, phosphorylation of BID does not seem to be critical for its proapoptotic activity. However, lack of BID phosphorylation does effect the susceptibility of cells to However, our findings suggest that ATM-mediated phosphorylation of BID is not related to BID cleavage, for the following reasons: phosphorylation occurs many hours before the activation of caspases and the onset of apoptosis (Figure 3 and data not shown) . A relatively small amount of BID is phosphorylated (Figure 2) , and phosphorylation occurs also in response to extremely low, nonapoptotic levels of DNA damage (Figure 4) . Moreover, the BID-S61A/S78A mutant was not found to be more susceptible to cleavage than was wtBID (Figure 7) . Lastly, though TNFα relies on the generation of tBID to induce/enhance apoptosis (Yin et finding that the phosphorylation of BID occurs in response to extremely low levels of ionizing radiation and increases in an ionizing radiation dose-dependent manner (Figure 4) , we propose that BID acts as a sentinel of DNA double-strand breaks. BID might translate the damage into either cell cycle arrest/DNA repair processes (at low levels of damage) or apoptosis (at high levels of damage). In summary, this study raises the novel possibility that the BH3-only BID protein, a molecule that was previously considered to be active only as a proapoptotic factor, may also play a prosurvival role. If BID is indeed playing both a proapoptotic and a prosurvival function in the DNA-damage pathway, then it is an excellent candidate to link DNA repair processes and apoptosis. 
